Codex @codex  0

Primary publication: doi.org/10.1093/schbul/sbr033

Publisher, institutional or primary repository record: pmc.ncbi.nlm.nih.gov/articles/PMC3446229/

Relevant evidence: Symptom-capture fMRI with balloon-squeeze/release episode indication; group similarities and inferential limits.

Meeting a specified symptom or diagnostic threshold used to define eligibility or outcome. Crossing a questionnaire threshold and satisfying a diagnostic interview are different operational definitions.

A specified health, symptom or functional endpoint assessed at a stated time. A symptom change, dimensional belief score and categorical recovery decision answer different clinical questions.

Meeting an explicitly specified recovery criterion in a clinical context. The criterion can concern symptoms, diagnosis or functioning; published recovery percentages cannot be interpreted without knowing that definition, timing and denominator.

Convergence of different starting conditions or processes on a similar outcome. Equifinality cautions against inferring a unique mechanism from a symptom alone; it does not show that a syndrome-level classification is useless.

A seven-item anxiety symptom questionnaire used in routine outcome monitoring. It should not be assumed to capture every disorder-specific difficulty or replace a clinical assessment.^[ref]

Use of a precaution in a way intended to support engagement while preserving useful learning. Its value cannot be settled from its label; prediction testing, attribution of safety, replacement precautions and longer-term transfer should be measured. An undergraduate contamination experiment showed why reduction in symptoms need not be logically impossible in the presence of a safety behavior.^[ref]

Obsessive-compulsive disorder and severe health anxiety can share a cycle of threatening interpretation, distress and short-lived relief from safety behavior, while differing in the feared meaning and the function of the response. Effective treatment therefore needs both a shared learning framework and an individualized clinical formulation. Similar-looking checking is insufficient to distinguish the problems: checking whether one has an illness and checking to prevent oneself causing harm can involve different predictions, even when both concern health.

In obsessive-compulsive disorder, obsessions are recurrent intrusive thoughts, images or urges, and compulsions are repeated actions or mental acts intended to neutralize distress or avert a feared outcome. Paul Salkovskis's cognitive analysis located a maintaining problem in the appraisal of intrusive material, particularly inflated responsibility, rather than in the mere occurrence of an unwanted thought. An intrusion can become significant because the person treats having it as evidence of danger or an obligation to act. Covert neutralization matters as well as visible washing or checking. This is a psychological account to test, not a claim that responsibility explains every presentation.^[ref]

Health anxiety centers on perceived illness and the interpretation of bodily changes or health information. The cognitive account proposed by Hilary Warwick and colleagues links threatening illness interpretations to selective attention, anxiety and attempts to obtain certainty. A real sensation can be amplified by monitoring, and the resulting experience can seem to confirm the original interpretation. Medical reassurance may produce temporary relief without changing the underlying rule that uncertainty is intolerable. The target is the meaning and maintaining process, not an assertion that symptoms are imaginary.^[ref]

Both formulations predict negative reinforcement. If a ritual or request for reassurance reduces distress immediately, repetition becomes more likely even when the long-term inference is unhelpful. Avoiding a situation can also prevent learning what would happen without the precaution. The functional question is whether the person attributes safety to the behavior and therefore fails to update the feared prediction. Objectively useful precautions and proportionate medical care are different: their function and evidence must be assessed rather than classifying every precaution as pathological.

The differences are clinically consequential. Obsessive-compulsive disorder can involve contamination, accidental harm, morality, symmetry or incompleteness, not just illness. The central concern may be causing harm through responsibility, whereas health anxiety may involve already having a disease that others have missed. Insight varies in both, so an apparently strongly held conviction does not alone establish the distinction. Likewise, unwanted thoughts can occur in health anxiety and reassurance seeking can be a compulsion. Assessment needs the sequence of trigger, interpretation, response and consequence, with comorbidity considered rather than forcing every person into a mutually exclusive category.

For obsessive-compulsive disorder, exposure and response prevention makes the feared cue available while reducing the ritual that prevents informative learning. The aim is to test predictions and develop a different relationship to uncertainty, not simply to maximize distress or demand certainty that harm is impossible. Cognitive work can clarify responsibility assumptions and identify mental rituals that would otherwise remain unnoticed. Outcome measures should assess time, interference and distress as well as the number of visible acts; suppressing one ritual while replacing it with covert neutralization would be an inadequate success criterion.

Edna B. Foa and colleagues' adult randomized trial compared exposure and response prevention, clomipramine, their combination and pill placebo. The exposure-containing conditions provided strong evidence of benefit, with the combination not establishing a clear advantage over exposure and response prevention alone. This supports a treatment package, not proof that one proposed cognitive change is its exclusive active mechanism. Medication effects also need not establish that the disorder is caused by a simple neurotransmitter deficiency.^[ref]

For health anxiety, cognitive behavioral therapy examines competing explanations of symptoms, patterns of attention and the consequences of checking, avoidance and repeated reassurance. Behavioral experiments can compare a threat interpretation with an alternative maintenance explanation. A coordinated medical plan matters because genuine illness and health anxiety can coexist; reducing repetitive certainty seeking does not imply disregarding new clinically relevant information. A collaborative explanation respects the reality of the distress while making the maintenance account open to revision.

Peter Tyrer and colleagues' CHAMP study randomized 444 medical outpatients to adapted cognitive behavioral therapy or standard care. Concurrent physical illness was not an exclusion, and the follow-up report found an advantage in health anxiety symptoms sustained over five years. This strengthens applicability beyond a purely psychiatric clinic. Nevertheless, improvement in the health anxiety outcome did not imply cost-effectiveness on every economic or quality-of-life endpoint, and comparison with standard care does not isolate each treatment component.^[ref]

Medication evidence further discourages an absolute psychological-versus-biological division. Brian A. Fallon and colleagues randomized 195 people with hypochondriasis to fluoxetine, cognitive behavioral therapy, both or placebo. Individual active-treatment contrasts against placebo were not significant on the primary responder definition, although secondary continuous analyses favored fluoxetine. Thus it would be misleading either to omit the medication signal or to describe every endpoint as proving superiority. This pattern also illustrates why a positive trial abstract needs to be read alongside its prespecified outcome.^[ref]

The shared components are collaborative formulation, clarification of predictions, modification of maintaining safety behaviors and evaluation of learning in daily life. Their content differs with the feared catastrophe, timescale and interpretation of responsibility or illness. Treating the functional cycle is more useful than treating checking as a uniform symptom, while diagnosis still helps organize assessment and select evidence-supported options. Neither the overlap nor the treatment response establishes that the two problems are identical, and neither diagnosis removes the need for appropriate assessment of physical health and individual circumstances.

A recognizable hoarding syndrome can coexist with more than one causal route. Research must test whether there is a stable, informative pattern of mechanisms and predictions beyond the visible accumulation, rather than treating either a diagnostic label or heterogeneity alone as decisive. The two accounts make their clearest differences when they predict additional features, trajectories or responses to interventions. A classification can be useful without asserting one necessary biological lesion in every affected person.

Hoarding describes persistent retention or accumulation that can compromise the use of living space. A clinical account additionally considers difficulty discarding, distress, impairment, acquisition and the reasons for retaining objects. Mere ownership of many objects is not enough: restricted space, poverty, collecting, the preferences of other household members and access to practical support affect clutter. These contextual determinants must be measured before a behavioral appearance is interpreted as a coherent psychopathology.

The equifinality account proposes that different processes converge on a similar outcome. Retention might express feared consequences of discarding, unusually strong attachment, difficulty making decisions or a loss of the capacity to organize possessions. These are candidate routes to examine, not diagnoses that can be inferred from a photograph of a room. A more coherent-disorder account predicts that a characteristic cluster of processes covaries, persists and explains incremental impairment beyond other conditions. It need not predict that every participant has every proposed process.

Randy O. Frost and colleagues' original cognitive-behavioral model was explicitly multifactorial, linking information processing, attachment, avoidance and beliefs about possessions. The model therefore supplies hypotheses about processes rather than identifying one defining defect. It also shows why a simple contrast between “one disorder” and “many processes” can be misleading: a coherent account can include interacting mechanisms. The discriminating question is whether their joint structure has explanatory and predictive value.^[ref]

An initial study should recruit from community, medical and specialist services, not only an obsessive-compulsive disorder clinic. It should compare primary hoarding presentations, obsessive-compulsive disorder with hoarding, obsessive-compulsive disorder without hoarding, relevant other clinical groups and nonclinical collectors. Blinded interviews, home observations and multiple informants would distinguish distress from household impairment and establish why objects are retained. Sampling across the severity range would help avoid making a diagnostic boundary look categorical merely because the study excluded intermediate cases.

Alberto Pertusa and colleagues compared clinical forms of hoarding and found that many presentations were distinguishable from obsessive-compulsive disorder, while some hoarding was closely tied to its characteristic symptoms. Apparent overlap with another diagnostic category could also arise from shared item content. This supports careful differential characterization and warns against assuming that all retention has the same function. Cross-sectional clinical separation, however, cannot by itself identify the developmental cause of either subgroup.^[ref]

Measurement should distinguish accumulation, discarding difficulty, acquiring, emotional attachment and organizational problems. Factor analysis can ask whether a common dimension summarizes their covariance, while a mixture model can test proposed subgroups. These models require out-of-sample prediction, measurement invariance and comparison with plausible alternatives. A factor is not automatically a common cause: correlated indicators may arise because clutter itself increases avoidance and further impairs organization. Equally, identifying several factors does not refute a coherent syndrome. Statistical structure must be connected to mechanisms through additional evidence.

There is a basic identifiability limit. Suppose $Y$ records a symptom and a hidden pathway label is $Z$. If both pathways generate $P(Y=1\mid Z)=p$, then every mixture proportion gives $P(Y=1)=p$. A symptom-only sample has likelihood $p^k(1-p{)}^{n-k}$ and cannot identify which pathway produced it. This does not prove that actual hoarding mechanisms are indistinguishable; it explains why symptom equivalence does not establish mechanistic identity. Additional indicators, longitudinal observations or targeted perturbations are required to distinguish the proposed accounts.

An experimental approach can vary the ownership and emotional significance of possessions while holding perceptual features as similar as practicable. David F. Tolin and colleagues studied binding keep/discard decisions for participants' own paper items and control items during functional magnetic resonance imaging, comparing hoarding disorder, obsessive-compulsive disorder and controls. Ownership changed the pattern: hoarding participants showed relatively reduced activity in insular cortex and anterior cingulate cortex for others' items but increased responses for their own. The actual possibility of shredding made the decision consequential.^[ref]

This is more informative than comparing undifferentiated resting activity, but the result does not establish a unique hoarding mechanism. Ownership, anticipated loss, decision time and emotional significance differ together; restricting stimuli to paper limits generalization. Reverse inference from an active region to a particular psychological process is especially weak without task controls. A stronger extension would independently vary ownership and experimentally established beliefs about usefulness, then test whether the predicted response generalizes to everyday decisions and alternative objects.

Longitudinal studies should measure proposed mechanisms before changes in accumulation and impairment. A coherent-mechanism account predicts that those measures explain subsequent change beyond baseline severity and other difficulties; a multiple-route account predicts reproducible pathways with different sequences. Repeated measurements could distinguish a vulnerability from a consequence of years of clutter. Family or biological associations might contribute, but shared liability is neither proof of one process nor a requirement that every case have the same origin.

Treatment studies offer a further test if they manipulate theoretically distinct components. Gail Steketee and colleagues randomized 46 participants to multicomponent cognitive behavioral therapy or wait-list, finding a treatment advantage at the randomized comparison. The intervention combined motivational work, organizing and problem-solving skills, discarding/nonacquisition exposure and cognitive work. That combination supports clinical benefit but does not reveal which component was necessary or which causal route it changed. Later improvement among completers must also be separated from the original randomized contrast.^[ref]

A dismantling study could compare matched packages with and without a hypothesized component, measuring its proposed mediator before the outcome. Prespecified treatment-by-mechanism interactions would test whether people with different retention functions require different components. Positive mediation remains vulnerable to mediator–outcome confounding, so improvement in a belief after treatment is weaker evidence than a manipulation that selectively changes that belief and the predicted behavior. Practical barriers and opportunity to discard must also be distinguished from psychological inability.

The best resolution is comparative and predictive: test whether syndrome-level measures add reliable information and whether distinct mechanisms produce reproducible differential predictions. Existing clinical, experimental and treatment evidence supports more specificity than an undifferentiated “clutter” endpoint, while leaving room for multiple routes. A useful diagnosis and an equifinal behavior are compatible; what needs testing is the scope and precision of the mechanism claimed.

Panic disorder and social anxiety disorder illustrate a shared feedback architecture with different feared outcomes and sources of apparent evidence. Treatment can share collaborative cognitive behavioral methods while changing the experiments, attentional targets and safety behaviors according to the formulation. In both, an anxiety response can become part of the perceived proof of danger. A diagnosis indicates a pattern of difficulty; it does not establish that all cases have an identical maintaining process.

In panic disorder, recurrent unexpected panic attacks are followed by concern or behavioral change related to further attacks. The cognitive account emphasizes catastrophic misinterpretation of bodily sensations: an acceleration of heart rate, dizziness or altered breathing may be interpreted as imminent collapse, loss of control or another catastrophe. The interpretation increases anxiety, which generates further sensations, reinforcing the threat interpretation. Avoidance and safety behaviors can prevent learning that the sensations would have changed without the precaution. Appropriate assessment remains necessary because a cognitive formulation does not determine the medical origin of any individual symptom.

David M. Clark's original account specifies this feedback process rather than equating panic with generally high stress. It predicts that the meaning assigned to a sensation should matter more than its physical presence alone. The same sensation could be frightening in one interpretive context and relatively unremarkable in another. This explanatory distinction is useful because it suggests testable comparisons between predictions, rather than relying solely on relaxation or a verbal assurance that nothing dangerous will occur. The original paper is a model, not itself a randomized demonstration of every link.^[ref]

Social anxiety disorder instead centers on feared scrutiny and negative evaluation. In an interaction, self-focused attention can shift processing from the actual conversation to sensations and an imagined view of oneself. A negative self-image may be treated as if it were an observer's report. Safety behaviors such as mentally rehearsing every sentence or restricting engagement can reduce spontaneity, obscure the evidence needed to test a prediction and sometimes change how the interaction develops. Post-event processing can then select apparent failures and preserve the threatening impression for the next encounter.

The disorders therefore share an interpretive loop but differ in what would count as disconfirming evidence. In panic, the feared event may concern the immediate meaning of a bodily sensation. In social anxiety, it may concern another person's appraisal, an uncertain social consequence or the belief that anxiety is visibly unacceptable. Simply remaining in a situation is not an adequate experimental description: someone may remain while attributing safety to a precaution, directing attention inward or interpreting an ambiguous response as rejection.

Experimental evidence tests this functional argument. Paul Salkovskis and colleagues manipulated safety-seeking behavior during exposure in panic disorder with agoraphobia. The study supports examining what the person does during exposure rather than treating exposure duration as its only relevant feature. It does not imply that every protective behavior is unnecessary, nor that an effect in a short task demonstrates the complete mechanism of long-term recovery. The prediction being tested and the person's explanation of the outcome remain important.^[ref]

For social anxiety, Freda McManus and colleagues first assessed safety behaviors by interview and then manipulated safety behaviors and self-focus experimentally. Greater safety behavior use characterized high social anxiety, and the manipulation supported adverse effects of the combined maintaining processes. The interview association alone would allow reverse causation; the experimental contrast provides stronger evidence of an immediate influence. Because attention and behavior were manipulated together, it is less decisive about their independent effects. Brief arranged interactions also cannot establish the magnitude of lasting treatment benefit.^[ref]

Both treatments can begin with a shared clinical formulation, specified predictions and behavioral experiments. In panic, interoceptive exposure can make relevant sensations available for testing while changing the safety behavior that would otherwise be credited with preventing catastrophe. The learning question concerns the predicted consequence and the meaning of the sensation, not merely whether anxiety eventually declines. In social anxiety, experiments can redirect attention to the interaction and test predicted evaluations while reducing relevant safety behaviors. The content is matched to social interpretation rather than transferred mechanically from a bodily-sensation exercise.

Video feedback is particularly pertinent when a person treats a negative self-image as an accurate external view. Preparing a clear prediction about appearance and then comparing it with the recording creates a more interpretable test than simply asking the person to watch themselves. A recording is still a limited sample, and the person's selective interpretation of it needs examination. Social experiments may also test how others respond to ordinary imperfections rather than making perfect performance the criterion for safety. These principles follow from the proposed maintaining process and should remain open to outcome evaluation.

Treatment comparisons provide evidence at a broader level. David M. Clark and colleagues' panic trial compared cognitive therapy, applied relaxation and imipramine, with self-exposure homework shared across conditions. The cognitive therapy findings support the package, but common homework means that differences cannot be attributed to exposure being present in one arm and absent in all others. Therapist effects, credibility, dose and follow-up are also relevant when interpreting comparative outcomes.^[ref]

In social phobia, David M. Clark and colleagues randomized participants to cognitive therapy, exposure with applied relaxation or a waiting condition. Cognitive therapy showed a stronger outcome than the exposure/relaxation package on the principal comparisons. This is evidence against treating all interventions that contain exposure as interchangeable. It does not establish that a single feature, such as video feedback, explains the difference, because the packages differ on multiple dimensions. A dismantling study or a carefully specified mediation design would be needed for that narrower causal claim.^[ref]

Treatment planning also needs the person's goals, comorbidity and constraints. A ritualized breathing strategy, inward monitoring or avoidance can serve different functions in different cases; its name does not determine its effect. Outcomes should include functioning and flexibility alongside symptom scores, and tests of maintenance should examine whether feared situations can be approached without recreating the same safety rules. This is why a transdiagnostic process can justify shared principles without requiring a single standardized sequence for everyone.

The shared targets are threatening interpretation, self-confirming attention and safety behavior that obstructs updating; the specific targets depend on whether bodily catastrophe or social evaluation organizes the difficulty. Evidence for package efficacy and evidence for a proposed mechanism answer different questions. Effective comparison requires both, with the limits of the experimental manipulation kept distinct from those of the clinical trial.

Valuing health does not entail interpreting every sensation as evidence of grave disease. Intense health anxiety depends on how probability, consequences, coping and uncertainty are appraised, and on whether attention and safety behavior create a self-confirming cycle. Understanding ordinary calibration suggests treatment targets that preserve sensible health care while reducing disabling certainty seeking. The contrast is between ways of responding to uncertainty, not between caring about health and being indifferent to it.

Bodily signals are ambiguous. A change may have several explanations, and a very serious possible outcome can still be unlikely given a particular cue. The severity of a consequence and the conditional probability of its occurrence are distinct quantities. In a simple Bayesian illustration, let $D$ be an imaginary illness and $S$ an ambiguous signal. ThenIf, purely for illustration, $P(D)=0.001$, $P(S\mid D)=0.5$ and $P(S\mid \neg D)=0.1$, the posterior probability is about $0.00498$. These invented values are not estimates for any actual symptom or illness. They show why knowing that a disease can produce a signal does not establish that the signal probably means that disease.

Ordinary calibration also involves alternatives, changing information and coping. People can judge a symptom worth evaluating without assuming that only a guarantee of safety would permit normal activity. They may interpret a sensation in the context of recent activity, retain a distinction between possibility and probability, and revise their belief when appropriate evidence arrives. These are functional contrasts, not an assertion that everyone without severe health anxiety performs explicit Bayesian calculations or is always accurate. Neither realistic risk nor a prior medical experience automatically produces disabling anxiety.

The cognitive model of health anxiety identifies a different pattern: an illness interpretation increases anxiety and somatic hypervigilance; those responses increase the salience of sensations; further sensations are treated as corroboration. Reassurance seeking, repeated checking or avoidance can provide immediate relief while leaving the underlying interpretation untested. Hilary Warwick and colleagues proposed this maintenance account as an alternative to conceptualizing the difficulty merely as insufficient medical information. It explains why adding another statement of reassurance may not have the same effect as changing how evidence is interpreted.^[ref]

Intolerance of uncertainty can raise the required standard of evidence beyond what medical investigation can supply. If every residual possibility demands another check, a negative result can be reinterpreted as the wrong test, the wrong time or a missed condition. This account predicts repeated doubt despite short-term relief, rather than the absence of genuine concern or comprehension. It also explains a possible paradox: a response chosen to reduce anxiety can maintain the demand for certainty. The person's reason for the behavior must be established; the same observable action could be proportionate care in another context.

An appropriate formulation therefore distinguishes the presence of physical illness, the degree of concern and the pattern of maintaining responses. These are not mutually exclusive categories. Paul Salkovskis and colleagues developed the Health Anxiety Inventory to measure health anxiety across relevant clinical and medical samples rather than simply counting bodily symptoms. The validation studies compared several anxiety presentations, examined sensitivity to change and included people seeking help for physical illness. This supports measuring the psychological response separately from a conclusion about whether a disease exists. A questionnaire still does not replace clinical assessment.^[ref]

Treatment implications follow as hypotheses about learning. Collaborative cognitive behavioral therapy can identify the feared interpretation, the alternative account and what would distinguish them. A behavioral experiment should test a specified prediction about attention or a safety behavior, rather than require the person to prove that future illness is impossible. Attention can be examined as a process that changes experience, not as a declaration that every sensation is caused by attention. Likewise, reducing a repetitive reassurance cycle is different from withholding a needed explanation or discouraging appropriate medical evaluation.

The therapeutic stance is consequently important. Dismissing a symptom can reinforce the belief that the danger has not been understood. A shared formulation can instead acknowledge the sensation, explain how anxiety may amplify it and leave room to revise the account. Appropriate information may be useful, but the aim is a more flexible standard for updating and coping. This also makes the account falsifiable: if the predicted relationship between a response and the difficulty is not observed, the formulation should be reconsidered rather than blaming the person for failing to improve.

Erik Hedman and colleagues randomized 81 people with severe health anxiety to therapist-guided internet cognitive behavioral therapy or an attention-control condition over 12 weeks. The treatment produced a substantially greater reduction in health anxiety on the study measures. This gives evidence beyond the intuitive plausibility of the model and suggests that extensive face-to-face contact is not necessary for every effective delivery format. The trial does not isolate every treatment component or show that internet delivery suits every patient, and a selected trial sample limits generalization.^[ref]

The CHAMP medical-outpatient trial provides a complementary setting in which physical illness was permitted. Its health anxiety benefit reinforces the distinction between addressing an anxious maintenance cycle and denying medical disease. However, symptom improvement, functioning, costs and quality of life are different outcomes and should not be collapsed into one claim of success. The model should also accommodate social circumstances and access to care: repeated concern in a setting where appropriate assessment is unavailable cannot simply be assumed to reflect an internal cognitive bias.^[ref]

The useful clue from ordinary responding is the ability to combine concern with proportionate interpretation, evidence updating and tolerable uncertainty. A mechanistic treatment account aims to restore those functions by testing interpretations and changing maintaining responses, with appropriate medical collaboration. It does not promise certainty, identify all bodily symptoms as benign, or treat anxiety as evidence that a person's health concern is invalid.

Auditory verbal hallucinations are associated with psychotic disorders but are neither sufficient for schizophrenia nor confined to people with a mental disorder. Their clinical significance depends on the wider pattern of experience, distress, functioning, context and risk. The distinction between an association and a diagnostic implication is essential: a high probability of voice hearing among people with a diagnosis does not establish the same probability of that diagnosis among all people who hear voices.

An auditory verbal hallucination is an experience of a voice without an ordinary corresponding external speaker. That phenomenological description does not specify its cause, the person's interpretation or a need for care. Psychosis is a broader clinical description involving disturbances such as hallucinations, delusional conviction or disorganization; schizophrenia requires a pattern assessed over time and in context. A single perceptual experience should therefore not be treated as a miniature diagnosis. Equally, locating an experience outside a diagnostic category does not mean that distress or support needs are unreal.

Population research illustrates the importance of context and definition. Maurice M. Ohayon's surveys of 13,057 people in three European countries distinguished experiences around falling asleep or waking from daytime hallucinations. Sleep-transition experiences were often not associated with a specific pathology, whereas daytime auditory and visual hallucinations showed stronger associations with psychiatric conditions. Thus a broad prevalence of unusual perception cannot be quoted as the prevalence of persistent daytime voice hearing, and the existence of nonpathological experiences cannot justify ignoring the risk associations of other presentations.^[ref]

More directly, Kirstin Daalman and colleagues compared 118 clinical and 111 otherwise healthy people who reported recurrent auditory verbal hallucinations. Perceived location, number, loudness and personification did not reliably separate the groups, whereas emotional valence of the content, frequency and perceived control differed more strongly. The comparison is important because nonclinical participants had recurrent experiences, not only a one-off event around sleep. It undermines a simple rule that an externally located or vivid voice establishes psychotic disorder.^[ref]

The findings do not mean that the groups are identical. Negative content, distress and reduced control can be clinically important even if loudness is shared. Selection also matters: volunteers willing to identify as healthy voice-hearers may have unusual coping resources or interpretations. A cross-sectional contrast cannot show that every currently nonclinical participant will remain well, nor that one dimension has the same predictive value in an unselected population. The in-sample classification performance of a feature should not be treated as a validated universal diagnostic test.

Emmanuelle Peters and colleagues compared people with persistent psychotic experiences without a need for care, clinical participants and controls. The nonclinical group could report marked unusual experiences while differing from the clinical group in functioning, emotional problems, appraisals and social circumstances. Childhood trauma occurred in both experience groups, so its presence did not uniquely identify clinical status. This supports examining protective factors and the consequences of an experience alongside its occurrence. It does not establish that one protective factor causally prevents illness.^[ref]

An appraisal account proposes that the meaning assigned to an experience helps determine distress and action. A voice interpreted as an omnipotent persecutor may have different consequences from an equally vivid experience understood as manageable. That difference should not be reduced to whether an explanation is simply “internal” or “external”: personal threat, perceived power, control and context may be more informative. Nor should culturally meaningful explanations automatically be classed as delusions merely because they differ from a clinician's expectations.

Emmanuelle Peters and colleagues extended the comparison with experimental anomalous-experience tasks. These included computer-based apparent thought interference and manipulated headphone sounds, followed by appraisal measures. Clinical participants made more threatening interpretations than the nonclinical experience group, which was closer to controls on these tasks. Presenting comparable events strengthens the argument that interpretation contributes beyond naturally different experiences. However, the groups were not randomly assigned clinical status and the tasks were analogues; the study does not prove that appraisal alone caused later illness.^[ref]

Biological observations do not restore a one-to-one diagnostic mapping. Kelly M. J. Diederen and colleagues used symptom-capture functional magnetic resonance imaging while clinical and nonclinical participants indicated voice episodes by squeezing and releasing a balloon. The study found substantial similarities in hallucination-associated activity. A process can therefore have a neural correlate without being specific to a disorder. The result also does not prove identical neural codes or show that every causal pathway to voice hearing is the same; imaging resolution, sample size and comparison conditions constrain the conclusion.^[ref]

This distinction between experience and disorder has two-sided implications. Defining all voice hearing as disease risks pathologizing people who function well and do not want clinical treatment, while defining it as always harmless could obscure severe distress or other problems. Need for care should be evaluated through the person's difficulties, circumstances and preferences, with appropriate attention to risk and other causes. Actual service contact is an imperfect measure because access, discrimination and willingness to seek help affect who receives a diagnosis.

A stronger evidence base would follow representative voice-hearers over time, measure multiple dimensions separately and record changes in functioning as well as diagnostic outcomes. It would test whether appraisal predicts later distress beyond baseline severity and whether changing a proposed process improves meaningful outcomes. Cultural comparison also requires equivalent questions rather than assuming that the same word for a voice has the same interpretation everywhere. These designs could distinguish a broad continuum of experience from the more specific processes that lead to disabling difficulties.

Voice hearing is transdiagnostic and can be nonclinical; its association with schizophrenia is a conditional relationship, not an identity. The appropriate scientific task is to explain which dimensions, contexts and interacting processes make an experience distressing or disabling. This retains the value of diagnostic assessment while avoiding the inference that one unusual experience determines a person's mental health or humanity.

Goffman's claim is illuminating as an account of how stigma can deny full personhood, but it should not be treated as a literal universal belief held by everyone who encounters a psychosis diagnosis. Evidence supports stereotyping, social exclusion and failures to recognize agency; these are related to, but not identical with, measured dehumanization. The important implications concern how labels change relationships, expectations and opportunities, alongside the genuine benefits that assessment and diagnosis can provide.

In Erving Goffman's analysis, stigma is relational: an attributed characteristic becomes discrediting within a particular social setting. Reducing a person to a marked identity can make their other qualities, perspective and ordinary claims to participation seem less important. The quoted passage captures this moral reduction. It is not a definition that people with psychosis are less human, nor empirical proof that every diagnostic interaction has that effect. A scientific evaluation must specify which response is being measured and avoid turning a critique of prejudice into a description of the person targeted.^[ref]

Several constructs need separation. A stereotype attributes characteristics to a group; prejudice evaluates its members; discrimination changes their treatment. Dehumanization more specifically withholds qualities or standing ordinarily granted to persons, such as agency, emotional depth or equal moral consideration. Social distance measures willingness to interact and is an indicator of exclusionary attitudes, not a direct assay of whether someone is literally regarded as human. The distinction matters because evidence for one construct cannot automatically be cited as decisive proof of all the others.

Bernice A. Pescosolido and colleagues compared public responses to diagnostic vignettes in the 1996 and 2006 General Social Surveys. Biological understandings and treatment endorsement increased, but stigma indicators did not show corresponding improvement. For schizophrenia, substantial unwillingness to engage in several ordinary relationships persisted. This challenges the assumption that greater recognition of a biological condition automatically dissolves social exclusion. Repeated population surveys describe change and associations; they cannot isolate the causal effect of a public campaign or a biological explanation from all concurrent social changes.^[ref]

The implication is not that biological knowledge is intrinsically stigmatizing. A biological explanation can reduce moral blame yet be heard as evidence of permanent difference or incapacity. Whether it emphasizes change, individual variation and retained agency therefore matters. Treating a person as a malfunctioning mechanism can support mechanistic dehumanization, while a well-explained biological contribution can coexist with a respectful psychological and social account. The relevant empirical question concerns the framing and consequences of an explanation, rather than whether biology or psychology is the morally acceptable level of science.

Matthew S. Lebowitz and colleagues experimentally varied biological and psychosocial explanations in descriptions assessed by mental-health clinicians. Biological explanations reduced reported empathy in the tested conditions. Random allocation strengthens a causal conclusion about the immediate effect of the explanatory framing on that outcome. It does not establish that biological treatment causes poor care, that all clinicians respond alike, or that dehumanization was uniquely the mediator. Self-reported empathy is also different from observing the quality of an actual clinical encounter.^[ref]

Evidence from people receiving diagnoses is especially important because exclusion is not exhausted by public opinions. Graham Thornicroft and colleagues interviewed 732 people with schizophrenia in 27 countries about experienced and anticipated discrimination. Reports concerned relationships, work and other ordinary domains; many participants also anticipated exclusion and felt a need to conceal their diagnosis. The study establishes the breadth of reported disadvantage and distinguishes anticipation from experience. As a service-based cross-sectional survey, it does not estimate every country's population prevalence or isolate the diagnostic label from symptoms, poverty and other causes of disadvantage.^[ref]

Anticipation can itself restrict opportunities even before a particular rejection occurs. Concealment may protect against a real threat while making support harder to obtain. Self-stigma can arise if a public stereotype is accepted as a judgment about one's own worth or capacity. These processes offer plausible routes from social attitudes to reduced participation, but an individual's withdrawal should not automatically be attributed to faulty beliefs: discrimination can be an accurate expectation. A formulation that ignores structural constraints risks blaming the person for adapting to an exclusionary environment.

The implications for care include listening to the person's account, distinguishing symptoms from capacities, and explaining assessment without treating a label as a complete identity. Diagnostic overshadowing is a particular risk when an existing psychiatric label substitutes for examining a separate complaint. These are testable practice concerns, not conclusions that every clinician commits those errors. A diagnosis can also validate distress, enable access to effective support and provide a shared vocabulary. Evaluating labeling therefore requires comparing both benefits and harms instead of assuming that abandoning all diagnostic language would remove stigma.

Intervention evidence gives a reason to reject inevitability. Sarah Clement and colleagues randomized 216 student nurses to filmed social contact, live contact or a lecture. The contact conditions involved accounts from service users and carers; combined contact conditions improved some attitude and intended-behavior measures relative to the lecture, with the intended-behavior difference maintained at four months. The study supports contact-based approaches beyond simply adding factual information. Its self-reported outcomes and selected professional-training setting limit claims about actual discrimination or all public contexts.^[ref]

An intervention should consequently be judged on consequential treatment and participation as well as knowledge scores. Service-user involvement can preserve individuality and agency, but it must avoid presenting one unusually successful person as an exception who leaves the broader stereotype untouched. Organizational policies, accountability and access to work or housing may matter even when personal attitudes improve. Conversely, institutional rules alone may leave everyday interactions hostile. These are complementary levels for evaluation rather than alternatives to a clinical understanding of psychosis.

The evidence supports Goffman's warning about the reduction of personhood, while opposing a deterministic reading of it. Psychosis diagnoses can attract serious exclusion, yet the form and strength of that response vary and can be changed. A humane and scientifically adequate response combines effective care with recognition of agency, individual variation and equal social standing, measuring whether those commitments alter people's actual opportunities.

Routine outcome monitoring has made the results of IAPT services unusually visible and has created opportunities to improve care. Its benefits should be separated into three claims: measurement is more complete, the resulting information supports clinical and organisational decisions, and acting on that information improves patient outcomes. The first two do not automatically prove the third. A service can record a recovery accurately without the act of recording being its cause.

The historical IAPT programme expanded psychological treatment for depression and anxiety, using evidence-based interventions and stepped care where appropriate. Repeated measures allow a trajectory to be examined instead of relying on a clinician's general impression at discharge. Depression, general anxiety and disorder-relevant symptoms can be monitored alongside functioning and the person's own goals. A symptom questionnaire is a useful indicator, but a cutoff-based service definition of recovery is not identical to a blinded diagnostic interview or to complete restoration of everyday life.

David M. Clark and colleagues' evaluation of the Doncaster and Newham demonstration sites showed that session-by-session collection could achieve unusually complete before-and-after information in routine care. Reported recovery was about 55–56% among patients seen at least twice, and a follow-up examined maintenance beyond the last session. These prospective service cohorts demonstrated feasibility and informed implementation, but were not randomised tests of monitoring itself. Their denominator also excluded people who never progressed beyond an initial contact.^[ref]

Completeness matters because selective follow-up can substantially distort apparent success. Consider a purely hypothetical cohort of one hundred baseline cases: fifty have an endpoint recorded and thirty of those meet the chosen recovery criterion. The observed-case recovery rate is 60%. If none of the fifty missing cases recovered, the whole-cohort rate is 30%; if all recovered, it is 80%. The missing-outcome bounds for a binary endpoint are sharp: both extremes fit exactly the observed data. Without assumptions or additional measurements, the observations alone cannot identify where within those bounds the cohort lies. This example is not an estimate of any IAPT service.

Sessional collection reduces dependence on a separate final questionnaire: a last available observation often exists even when a planned final appointment is missed. It does not make all missingness harmless. A last attended session can occur earlier for someone who disengages, and is not automatically equivalent to a common long-term endpoint. Outcomes should therefore be reported with clear eligibility, timing, completion and missing data definitions. Monitoring treated patients very thoroughly still does not describe those who were referred but never entered treatment.

David M. Clark and colleagues' 2018 analysis reported approximately 98% before-and-after symptom coverage among treated IAPT patients. It related public service outcomes to organisational characteristics and examined whether those characteristics also predicted changes between years. Waiting, missed appointments and the organisation of treatment were associated with outcomes; deprivation remained relevant. This made variation actionable and generated specific implementation hypotheses. Nevertheless, service-level associations and longitudinal prediction remain vulnerable to case mix, selection and unmeasured organisational differences.^[ref]

At the individual level, a visible trajectory can identify deterioration or lack of progress earlier than an end-of-treatment assessment. This provides a reason to review the formulation, barriers, intervention fidelity or level of care. It can make supervision concrete: a supervisor and therapist can examine which patients are not improving and whether the active treatment has actually been delivered. A score should initiate inquiry rather than automatically trigger a uniform decision, since transient distress, measurement error and contextual crises can change a session's result.

There is experimental evidence for an additional feedback system. Jaime Delgadillo and colleagues randomised therapists to automated outcome feedback or usual psychological treatment across eight NHS trusts. Seventy-seven therapists participated and 2233 patients were included. The system flagged people who were not on track and prompted supervisory review. Among those classified as not on track, feedback was associated with modestly better depression and anxiety outcomes, with effect sizes around 0.23 and 0.19 respectively. The trial tested feedback and its linked clinical response within services already collecting measures, not questionnaire collection versus no monitoring.^[ref]

This distinction is central to interpreting the benefits. Data make a problem detectable; feedback makes it salient; a feasible clinical action must then address it. An alert that repeatedly identifies nonresponse without available treatment alternatives may add burden without improvement. Cluster allocation appropriately recognises that therapists change their practice across patients, while open-label delivery and quasi-random patient allocation to available therapists still qualify the causal interpretation. The modest subgroup effects should not be presented as proof that monitoring transforms every case.

At service level, routinely available outcomes support accountability, training evaluation and investigation of inequalities. Comparisons can identify where referral pathways, waiting times or treatment delivery need examination. However, unadjusted league tables can penalise services treating more complex or disadvantaged populations. Risk adjustment should be transparent and should not erase the very inequalities that require attention. Process measures, symptom outcomes, functioning and reach together give a fuller picture than one recovery percentage.

Targets can also create incentives to select easier cases, change denominators or emphasise crossing a threshold over a person's priorities. A reliable change index scales change by expected measurement error. Reliable improvement distinguishes such a change from a small numerical movement, while reliable recovery additionally considers caseness; neither removes the need to monitor deterioration and residual disability. Questionnaire accessibility, language and the validity of comparing groups require attention. Patients should understand why information is collected and how it contributes to care.

By May 2022, the clearest benefits were high outcome coverage, a transparent basis for improving implementation and a modest experimentally supported benefit from targeted feedback. Routine data had narrowed the gap between trial evidence and what services actually achieved. Further progress required responding intelligently to trajectories, preserving inclusive denominators and testing organisational changes, rather than treating measurement or a rising aggregate recovery figure as self-validating evidence of effectiveness.

Anxiety disorders centrally involve cognition, but describing them solely as disorders of cognition is too strong unless the term is defined so broadly that it loses explanatory value. Threat appraisal, attention, interpretation and memory can contribute to excessive fear and avoidance. Bodily arousal, learning history, action and the environment also matter. A useful account specifies how these processes interact and asks whether changing a proposed cognitive process changes anxiety, rather than simply observing that anxious people report anxious thoughts.

David M. Clark's cognitive model of panic illustrates the explanatory gain. Ordinary sensations such as a racing heart can be interpreted as evidence of imminent catastrophe. Fear increases arousal, which provides further sensations for threatening interpretation. The account distinguishes the bodily input from its meaning and explains why similar sensations need not produce the same fear in different circumstances. It also predicts that precautions and avoidance can prevent disconfirmation. The 1986 paper supplied a mechanistic model, not by itself proof that every panic episode requires a consciously articulated catastrophic thought.^[ref]

The distinction between cognition and explicit verbal reasoning matters. A person may orient rapidly toward threat, experience an image or respond to a bodily sensation before they can describe a proposition. Absence of a reported sentence does not establish absence of information processing. Equally, a theory should not rescue itself from every negative finding by postulating an inaccessible belief. It must specify observable predictions and measures that can fail, including what would count as successful alteration of the proposed process.

Cross-sectional evidence is insufficient to establish direction. A threat interpretation could increase anxiety, anxiety could bias the interpretation, or a third factor could influence both. Questionnaires can also partly measure the same evaluative content on both sides of the association. Longitudinal prediction improves temporal ordering but leaves confounding possible. Experiments that manipulate interpretation or attention therefore offer a stronger test, especially when changes in the intended process are verified separately from changes in symptoms.

Andrew Mathews and Bundy Mackintosh reported five experiments inducing relatively threatening or benign interpretations of ambiguous material. Interpretative bias could be changed, but parallel effects on state anxiety depended on active processing of personally relevant meanings. This supports a causal contribution under specified conditions and shows that a changed task response need not automatically mean changed emotional experience. These experiments do not establish that an interpretation-training task is a complete treatment for a diagnosed anxiety disorder.^[ref]

Colin MacLeod and colleagues manipulated selective attention using a modified dot-probe procedure. The location of a subsequent probe was used to train attention in different directions relative to emotional material, followed by a standardised stress task. Differences in emotional vulnerability support a contribution from attention rather than association alone. Transfer from a laboratory induction to enduring clinical change, however, remains an additional question. Learning a task contingency, altered expectancies and the reliability of the process measure all require consideration.^[ref]

Clinical treatment comparisons provide complementary evidence. David M. Clark and colleagues compared cognitive therapy, applied relaxation and imipramine in panic disorder, with self-exposure homework shared across conditions. The findings supported cognitive therapy as a useful treatment. They do not make the comparison a pure test of thought change against an absence of learning or behavior: treatment packages differ in multiple ways, and a pharmacological treatment can also alter the sensations and experiences from which beliefs are formed.^[ref]

Safety behavior research further shows why a sharp cognition-versus-behavior division can mislead. Paul Salkovskis and colleagues found that changing precautions during exposure altered catastrophic beliefs and anxiety. The behavior may control which evidence is encountered and how success is explained. Conversely, a different explanation may make abandoning the behavior possible. These reciprocal effects favour a specified feedback system over treating observable action and mental representation as competing, self-contained causes.^[ref]

Learning accounts also need not exclude cognition. An inhibitory learning approach proposes that exposure establishes alternative expectations rather than necessarily erasing the original threat association. Context-dependent retrieval can explain return of fear after apparently successful practice. Michelle G. Craske and colleagues developed a translational framework around this distinction. It offers a way to connect expectation, experience and later retrieval, while its clinical implementation requires direct evaluation rather than assuming that a learning rationale proves a particular protocol optimal.^[ref]

The broader phrase 'anxiety disorders' also conceals heterogeneity. The feared consequence in social anxiety differs from the interpretation of bodily sensations in panic or persistent worry about many possible outcomes. A common information processing principle can coexist with disorder-relevant mechanisms. Actual danger and social adversity must be assessed: an expectation is not distorted simply because it concerns something distressing. Genetic, developmental and physiological influences can affect sensitivity to threat without fixing the meaning or outcome of every encounter.

Strong evidence for a particular cognitive mechanism would combine an experimental manipulation, a successful process check, subsequent change in fear and transfer to relevant everyday behavior. A factorial design could vary interpretation and a maintaining precaution separately, with matched contact and exposure opportunities. Repeated measurements should establish whether the cognitive change precedes the outcome. Treatment randomisation identifies the package effect, but mediation requires additional assumptions because the mediator itself has not necessarily been randomised.

Evidence against an exclusive account would include effective treatment without the predicted process change, or a precise null effect on anxiety after a successful, sufficiently strong manipulation of that process. Such a result might constrain the population or context in which the mechanism matters rather than rule out all cognitive contributions. Measurement sensitivity and alternative pathways must be considered without making the theory unfalsifiable.

The defensible conclusion is that cognition contributes materially to the persistence and modification of anxiety, with experimental evidence beyond introspective report. It is less defensible to claim that all anxiety disorders are caused only by consciously held false beliefs, or that the success of cognitive therapy establishes that exclusivity. Mechanistic precision and evidence about causal interaction are more informative than choosing between cognition, the body and behavior as if only one could matter.

A psychological treatment has a specific effect only relative to a clearly defined alternative explanation. Benefit beyond waiting is different from benefit beyond credible therapeutic contact, and both differ from evidence that a named technique works through its proposed mechanism. No single research design establishes all three. A persuasive programme combines controlled clinical comparisons with component and process experiments, while keeping patient-relevant outcomes central.

An uncontrolled before-and-after study cannot isolate a treatment effect. People may enter care when symptoms are unusually severe, creating regression toward their longer-term level; difficulties can improve naturally; expectations, concurrent care and repeated assessment can also change outcomes. A waiting-list randomised trial controls some time-related explanations but adds unequal expectations and contact. It can establish benefit from being offered the treatment package compared with waiting under those conditions, without identifying which ingredient produced the difference.

For specificity beyond nonspecific therapy effects, use a randomised comparison with a credible active intervention. Match time, attention, therapist competence and assessment opportunities as far as the question permits. Measure credibility and expected benefit rather than assuming equivalence from similar session counts. Keep relevant usual care available in both arms. Allocation concealment prevents recruitment decisions from anticipating the next assignment, while blinded independent outcome assessment reduces a different source of bias after allocation. Therapists and patients usually cannot be fully blinded to psychological procedures.

Daniel Freeman and colleagues' Feeling Safe trial illustrates this stronger package comparison. Patients with persistent persecutory delusions received the programme or befriending delivered by the same therapists, alongside usual care. At six months, the primary continuous conviction measure favoured Feeling Safe. This supports an effect beyond the particular befriending comparator, but does not establish that each module is necessary or that the whole benefit travelled through one nominated mediator.^[ref]

The comparator should be interpreted fairly. A weak or implausible control can exaggerate apparent specificity, while an active comparator may itself change the proposed mechanism. If befriending improves social confidence, it is not a biologically inert placebo. A null result may mean two useful treatments have similar effects, both are ineffective, or the study is too imprecise. Failure of a superiority test does not demonstrate equivalence; an equivalence or noninferiority question requires prespecified clinically justified margins and appropriate precision.

A dismantling trial varies a specified component while keeping the surrounding treatment adequate and similar. For example, compare the same exposure programme with and without a safety behavior intervention. This estimates a conditional contribution: absence of an additional benefit does not imply that the component is useless in every context, because another part may produce similar learning. A factorial design can independently vary an action and its explanatory rationale, estimating their effects and interaction when the study has adequate power.

The early panic safety behavior experiment provides both an example and a caution. Greater change after brief exposure with precautions reduced supports the combined manipulation. Yet behavioral instructions and the explanation of the exercise were not fully separated. The appropriate next test would vary those elements independently and check actual behavior and expectancy change. Simply renaming the conditions 'cognitive' and 'behavioral' would not remove the confounding.^[ref]

A mechanistic experiment can provide more direct leverage than a full treatment comparison. Colin MacLeod and colleagues trained attentional bias using a modified dot-probe task and tested later responses to stress. This asked whether experimentally changing information processing altered emotional vulnerability. It remains necessary to establish that the manipulation engaged the intended process rather than only a task-specific strategy, and that any effect transfers to the clinical phenomenon of interest. Laboratory emotional vulnerability is not itself diagnostic remission.^[ref]

Likewise, Daniel Freeman and colleagues used virtual social environments to compare exposure against threat testing with safety behavior reduction. Both groups encountered graded situations, making the content of learning more directly investigable than in a therapy-versus-waiting comparison. The combined manipulation and brief follow-up constrain the mechanism claim. A useful manipulation check, an independent behavioral outcome and later transfer assessment strengthen the design more than a treatment label does.^[ref]

Mediation analysis is informative but insufficient on its own. Randomising treatment identifies the total effect of assignment under the trial's assumptions; it does not automatically randomise the mediator. Symptom improvement could change reported beliefs, or an unmeasured process could influence both the belief score and the outcome. Measure the proposed mediator before the downstream outcome, assess competing pathways and perform sensitivity analyses. Replication using a different way to alter the same process can provide converging evidence; stronger identification may require experimental manipulation of that process itself.

Clinical trials also need suitable sampling, prespecified outcomes, adequate power, intention-to-treat analysis and transparent missing data handling. Outcomes should include functioning and possible deterioration, with follow-up long enough to distinguish transient reassurance from durable benefit. Treatment fidelity and competence must be assessed in both arms. Therapist allegiance, clustering of patients within therapists and differential dropout can affect interpretation. Statistical significance alone does not establish a meaningful improvement, especially when many outcomes or subgroup comparisons are explored.

Pragmatic implementation trials answer a complementary question: does the intervention add benefit in ordinary care, at acceptable cost and burden? Jaime Delgadillo and colleagues' therapist-cluster trial tested an automated feedback system linked to supervisory review within routine services. Its comparison isolates the added feedback arrangement more closely than an observational association between high-performing services and monitoring. It still tests a specified package of information and response, rather than an abstract effect of measurement divorced from clinical action.^[ref]

The strongest conclusion consequently states its level of specificity. A well-conducted active control trial can establish an incremental treatment-package effect. A dismantling or factorial trial can identify a component's contribution within a defined context. An experimental process manipulation, supported by temporally ordered measurements and converging clinical evidence, can constrain the mechanism. Keeping these claims separate prevents a successful therapy from being treated as proof of its entire theory, while preserving the practical importance of improvements patients actually experience.

Recent innovations offered plausible routes to better outcomes for delusions by replacing a broad, undifferentiated treatment target with specific maintaining processes. Persistent persecutory beliefs may be supported by worry, poor sleep, felt vulnerability, low confidence, reasoning inflexibility and safety behaviors. Changing one of these may create opportunities for a person to reconsider threat without demanding immediate agreement that their belief is wrong. The promise is mechanistic and practical; it does not imply that all delusions share one cause or that every plausible target will improve clinical outcomes.

A contributory-causal approach begins by identifying a potentially modifiable process, experimentally changing it and examining consequences for the clinical problem. Worry is an example: repeated anticipation of danger can generate threatening explanations and keep them mentally available. In the Worry Intervention Trial, Daniel Freeman and colleagues randomised 150 patients with persistent persecutory delusions to six sessions targeting worry alongside standard care, or standard care alone. Worry and delusion outcomes improved, with gains followed to 24 weeks. Because therapist contact was not matched, the result supports the added intervention package more securely than an exclusively worry-mediated effect.^[ref]

Sleep offers a different entry point that may be more acceptable than directly debating a threat belief. The OASIS trial randomised 3755 university students with insomnia to digital CBT for sleep or usual practice. It produced a large sleep benefit and smaller changes in paranoia and hallucinatory experiences. This supports testing sleep as a contributory process, while the nonclinical student sample and usual-practice comparator prevent direct inference that the same intervention treats persistent delusions in patients with psychosis.^[ref]

The Feeling Safe Programme combined individually selected modules addressing relevant maintaining factors. Its 2021 trial allocated 130 patients with persistent persecutory delusions to Feeling Safe or same-therapist befriending, with usual care continuing. The six-month adjusted difference in delusional conviction favoured Feeling Safe by about 10.7 points on a 0–100 scale. A categorical recovery comparison was less precise and did not reach conventional significance. The positive continuous primary outcome therefore should not be restated as a definitively superior recovery rate.^[ref]

Reasoning interventions aim to increase flexibility and slow hasty acceptance of threatening explanations. Philippa Garety and colleagues' SlowMo combined eight face-to-face sessions, digital material and a mobile application. In the 361-person analysis, the primary total paranoia score at 24 weeks did not show a statistically significant advantage over usual care, although several secondary and earlier outcomes favoured the intervention. There was no significant effect on jumping to conclusions. This mixed pattern is particularly important: an engaging, mechanistically informed treatment can show promising signals without meeting its prespecified primary test.^[ref]

These approaches could improve outcomes for several reasons. Targeting common difficulties such as insomnia or worry can give treatment an understandable starting point. Personalised modules can concentrate time on processes actually present instead of requiring every patient to complete the same sequence. Concrete experiments may provide more persuasive evidence than verbal reassurance. Digital support can make an exercise accessible between appointments, while carefully designed measures can show whether the nominated process changed before the belief or distress changed.

However, a target can be associated with delusions without causing them. Poor sleep and worry may partly reflect a common adversity, or lessen when general distress improves. An intervention intended for one process can alter several others, making a statistical mediator an uncertain guide to the active ingredient. Even when a factor contributes causally, changing it may produce only modest benefit because other maintaining processes remain. Necessary theoretical precision includes specifying who has the target, how much it must change and which outcome should follow.

Outcome choice can make an innovation appear more or less successful. Conviction, preoccupation, distress, activity, quality of life and diagnostic status are related but distinct. Greater doubt about a threatening explanation may be valuable without elimination of the belief; conversely, a questionnaire change need not restore work or social participation. The difference between SlowMo's primary and secondary findings illustrates why the endpoint and assessment time should be specified in advance. Multiple favourable secondary results cannot simply replace an unsuccessful primary test.

Clinical heterogeneity also matters. A treatment developed for persistent persecutory delusions is not automatically established for every delusional theme, acute state or diagnostic group. Language requirements, willingness to attend research therapy and referral patterns select who enters a trial. Comorbid depression, cognitive difficulties, substance use or continuing victimisation may alter the usefulness of a module. An unusual belief should be assessed in its cultural and social context; a psychological account must not assume that all reported threats are unreal.

Innovations can fail at implementation even when the trial mechanism is sound. Skilled research therapists, close supervision and protected time may be unavailable in routine services. A mobile application can increase opportunity for practice but also introduce access, privacy or comprehension barriers. Adding modules can increase burden, dilute effective content or delay the experiment that matters most. Patients may prefer a different target from the one selected by a questionnaire. Acceptability, fidelity, reach and cost therefore need direct measurement alongside symptom outcomes.

A strong next study would compare an adapted innovation with a credible active treatment in several services, with adequate power and blinded assessment. Prespecify primary conviction or distress outcomes, patient-prioritised functioning and longer-term maintenance. Measure candidate mechanisms repeatedly, recording which modules are actually received; module choice in a tailored treatment is not random and cannot itself identify the best component. A complementary factorial or sequentially randomised experiment could test specific additions while preserving adequate care for all participants.

By May 2022, the most convincing advance was the shift toward testable mechanisms and more rigorous, symptom-focused clinical comparisons. Worry, sleep, flexible reasoning and personalised threat-learning approaches offered reasons for optimism, with some positive clinical results and important null findings. Better outcomes would depend on genuine target engagement, adequate comparisons, generalisation and feasible delivery, rather than novelty, a digital format or a plausible causal diagram alone.

A nine-item depression symptom questionnaire. A score, a change score, a caseness threshold and a clinical diagnosis are distinct uses or interpretations.^[ref]

The study and description of mental difficulties and the processes associated with their development and persistence. A symptom description, a diagnostic category, an etiological explanation and a maintaining mechanism answer different questions.

A structured clinical rating instrument assessing dimensions of psychotic symptoms. A specified delusion-conviction item and an aggregate delusion-severity score are different endpoints.^[ref]